Document is current
Any future updates will be listed below
-
Authors
Horita, Nobuyuki
Nagashima, Akimichi
Nakashima, Kentaro
Shibata, Yuji
Ito, Kentaro
Goto, Atsushi
Yamanaka, Takeharu
Kaneko, Takeshi
- License Information
-
More Information
Article History
Received: 5 May 2017
Accepted: 27 September 2017
First Online: 13 October 2017
Competing Interests
: This work was funded by Pfizer Health Research Foundation and JSPS KAKENHI Grant Number 17K09620. Nobuyuki Horita received a grant from Pfizer Health Research Foundation. Takeharu Yamanaka received lecture fee and/or grant from TAIHO Phamaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Eli Lilly Japan K.K., Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Yakult Honsha Co., Ltd., Sanofi K.K., Bristol-Myers Squibb. during the last three years. Takeshi Kaneko received lecture fee and/or grant from Pfizer Inc., SHIONOGI & CO., Ltd, TAIHO Phamaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., DAIICHI SANKYO C., Ltd, and Meiji Seika Pharma Co., Ltd. during the last three years. The other authors have no conflict of interests.
